Unknown

Dataset Information

0

The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV.


ABSTRACT: COVID-19 novel coronavirus (CoV) disease caused by severe acquired respiratory syndrome (SARS)-CoV-2 manifests severe lethal respiratory illness in humans and has recently developed into a worldwide pandemic. The lack of effective treatment strategy and vaccines against the SARS-CoV-2 poses a threat to human health. An extremely high infection rate and multi-organ secondary infection within a short period of time makes this virus more deadly and challenging for therapeutic interventions. Despite high sequence similarity and utilization of common host-cell receptor, human angiotensin-converting enzyme-2 (ACE2) for virus entry, SARS-CoV-2 is much more infectious than SARS-CoV. Structure-based sequence comparison of the N-terminal domain (NTD) of the spike protein of Middle East respiratory syndrome (MERS)-CoV, SARS-CoV, and SARS-CoV-2 illustrate three divergent loop regions in SARS-CoV-2, which is reminiscent of MERS-CoV sialoside binding pockets. Comparative binding analysis with host sialosides revealed conformational flexibility of SARS-CoV-2 divergent loop regions to accommodate diverse glycan-rich sialosides. These key differences with SARS-CoV and similarity with MERS-CoV suggest an evolutionary adaptation of SARS-CoV-2 spike glycoprotein reciprocal interaction with host surface sialosides to infect host cells with wide tissue tropism.

SUBMITTER: Awasthi M 

PROVIDER: S-EPMC7551769 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV.

Awasthi Mayanka M   Gulati Sahil S   Sarkar Debi P DP   Tiwari Swasti S   Kateriya Suneel S   Ranjan Peeyush P   Verma Santosh Kumar SK  

Viruses 20200819 9


COVID-19 novel coronavirus (CoV) disease caused by severe acquired respiratory syndrome (SARS)-CoV-2 manifests severe lethal respiratory illness in humans and has recently developed into a worldwide pandemic. The lack of effective treatment strategy and vaccines against the SARS-CoV-2 poses a threat to human health. An extremely high infection rate and multi-organ secondary infection within a short period of time makes this virus more deadly and challenging for therapeutic interventions. Despite  ...[more]

Similar Datasets

| S-EPMC7097669 | biostudies-literature
| S-EPMC7123399 | biostudies-literature
| S-EPMC8491549 | biostudies-literature
| S-EPMC9380817 | biostudies-literature
| S-EPMC7567490 | biostudies-literature
| S-EPMC7219414 | biostudies-literature
| S-EPMC4696701 | biostudies-literature
| S-EPMC7499654 | biostudies-literature
| S-EPMC8443317 | biostudies-literature
| S-EPMC7104183 | biostudies-literature